Yogesh R. Suryawanshi & Autumn J. Schulze. (2021) Oncolytic Viruses for Malignant Glioma: On the Verge of Success?. Viruses 13:7, pages 1294.
Crossref
Eftychia Stavrakaki, Clemens M. F. Dirven & Martine L. M. Lamfers. (2021) Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response. Cancers 13:4, pages 614.
Crossref
Andreas H. Jacobs, Sonja Schelhaas, Thomas Viel, Yannic Waerzeggers, Alexandra Winkeler, Bastian Zinnhardt & Juri Gelovani. 2021. Molecular Imaging. Molecular Imaging
1539
1587
.
Abdul Mohin Sajib, Maninder Sandey, Samantha Morici, Bradley Schuler, Payal Agarwal & Bruce F. Smith. (2020) Analysis of endogenous and exogenous tumor upregulated promoter expression in canine tumors. PLOS ONE 15:11, pages e0240807.
Crossref
Elisa Lozano, Rocio I.R. Macias, Maria J. Monte, Maitane Asensio, Sofia del Carmen, Laura Sanchez‐Vicente, Marta Alonso‐Peña, Ruba Al‐Abdulla, Patricia Munoz‐Garrido, Letizia Satriano, Colm J. O'Rourke, Jesus M. Banales, Matias A. Avila, Maria L. Martinez‐Chantar, Jesper B. Andersen, Oscar Briz & Jose J.G. Marin. (2019) Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy. Hepatology 70:4, pages 1246-1261.
Crossref
Brittany C. Parker Kerrigan, Yuzaburo Shimizu, Michael Andreeff & Frederick F. Lang. (2017) Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas. Cytotherapy 19:4, pages 445-457.
Crossref
J.W. Kim, J. Murphy, A.L. Chang, D.A. Spencer, J.R. Kane, D. Kanojia, A. Rashidi, J.S. Young & M.S. Lesniak. 2017. Mesenchymal Stromal Cells as Tumor Stromal Modulators. Mesenchymal Stromal Cells as Tumor Stromal Modulators
475
499
.
Anand C. Annan, Paul B. Fisher, Paul Dent, Gene P. Siegal & David T. Curiel. 2017. The Molecular Basis of Human Cancer. The Molecular Basis of Human Cancer
811
841
.
A.O. Sosnovtceva, N.F. Grinenko, A.V. Lipatova, P.M. Chumakov & V.P. Chekhonin. (2016) Oncolytic viruses for therapy of malignant glioma. Biomeditsinskaya Khimiya 62:4, pages 376-390.
Crossref
Perry T. Yin, Edward Han & Ki-Bum Lee. (2016) Engineering Stem Cells for Biomedical Applications. Advanced Healthcare Materials 5:1, pages 10-55.
Crossref
Julius W. Kim, Jacob S. Young, Elena Solomaha, Deepak Kanojia, Maciej S. Lesniak & Irina V. Balyasnikova. (2015) A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors. Scientific Reports 5:1.
Crossref
Hongpan Xu, Lailing Gong, Yanyan Xia, Lili Qu, Qiwen Li, Lu Pang, Jin Si & Zhiyang Li. (2015) Frizzled-7 promoter is highly active in tumors and promoter-driven Shiga-like toxin I inhibits hepatocellular carcinoma growth. Oncotarget 6:37, pages 39908-39923.
Crossref
Julius W. KimJ. Robert KaneJacob S. YoungAlan L. ChangDeepak KanojiaRamin A. MorshedJason MiskaAtique U. AhmedIrina V. BalyasnikovaYu HanLingjiao ZhangDavid T. CurielMaciej S. Lesniak. (2015) A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma. Human Gene Therapy 26:9, pages 635-646.
Crossref
I.V. Ulasov, A.V. Borovjagin, B.A. Schroeder & A.Y. Baryshnikov. (2014) Oncolytic adenoviruses: A thorny path to glioma cure. Genes & Diseases 1:2, pages 214-226.
Crossref
Rutger K. Balvers, Candelaria Gomez-Manzano, Hong Jiang, Sujan Piya, Sarah R. Klein, Martine L.M. Lamfers, Clemens M.F. Dirven & Juan Fueyo. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer
137
151
.
Yi Lu, Yu Zhang, Guimin Chang & Jun Zhang. (2013) Comparison of Prostate-Specific Promoters and the Use of PSP-Driven Virotherapy for Prostate Cancer. BioMed Research International 2013, pages 1-15.
Crossref
Haibin Xia. (2012) A novel Ad5/11 chimeric oncolytic adenovirus for improved glioma therapy. International Journal of Oncology.
Crossref
B Thaci, A U Ahmed, I V Ulasov, A L Tobias, Y Han, K S Aboody & M S Lesniak. (2012) Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model. Cancer Gene Therapy 19:6, pages 431-442.
Crossref
Mine Ergüven & Ayhan Bilir. 2012. Midkine: From Embryogenesis to Pathogenesis and Therapy. Midkine: From Embryogenesis to Pathogenesis and Therapy
283
303
.
Atique U. Ahmed, Matthew A. Tyler, Bart Thaci, Nikita G. Alexiades, Yu Han, Ilya V. Ulasov & Maciej S. Lesniak. (2011) A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant Glioma. Molecular Pharmaceutics 8:5, pages 1559-1572.
Crossref
Mahua Dey, Ilya V. Ulasov, Matthew A. Tyler, Adam M. Sonabend & Maciej S. Lesniak. (2010) Cancer Stem Cells: The Final Frontier for Glioma Virotherapy. Stem Cell Reviews and Reports 7:1, pages 119-129.
Crossref
Mahua Dey, Ilya V. Ulasov & Maciej S. Lesniak. (2010) Virotherapy against malignant glioma stem cells. Cancer Letters 289:1, pages 1-10.
Crossref
M. V. Mityaev, E. P. Kopantzev, A. A. Buzdin, T. V. Vinogradova & E. D. Sverdlov. (2010) Enhancer element potentially involved in human survivin gene promoter regulation in lung cancer cell lines. Biochemistry (Moscow) 75:2, pages 182-191.
Crossref
Suvobroto Nandi, Ilya V. Ulasov, Cleo E. Rolle, Yu Han & Maciej S. Lesniak. (2009) A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy. The Journal of Gene Medicine 11:11, pages 1005-1011.
Crossref
Jacqueline Nuss Parker, David F. Bauer, James J. Cody & James M. Markert. (2009) Oncolytic viral therapy of malignant glioma. Neurotherapeutics 6:3, pages 558-569.
Crossref
Poonam Balani, Jerome Boulaire, Ying Zhao, Jieming Zeng, Jiakai Lin & Shu Wang. (2009) High Mobility Group Box2 Promoter-controlled Suicide Gene Expression Enables Targeted Glioblastoma Treatment. Molecular Therapy 17:6, pages 1003-1011.
Crossref
Yannic Waerzeggers, Parisa Monfared, Thomas Viel, Alexandra Winkeler, Jürgen Voges & Andreas H. Jacobs. (2009) Methods to monitor gene therapy with molecular imaging. Methods 48:2, pages 146-160.
Crossref
A M Sonabend, I V Ulasov, Y Han, C E Rolle, S Nandi, D Cao, M A Tyler & M S Lesniak. (2008) Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats. Cancer Gene Therapy 16:4, pages 362-372.
Crossref
M A Tyler, I V Ulasov, A M Sonabend, S Nandi, Y Han, S Marler, J Roth & M S Lesniak. (2008) Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Therapy 16:2, pages 262-278.
Crossref
Adam M. Sonabend, Ilya V. Ulasov, Karen Dana & Maciej S. Lesniak. 2009. Therapeutic Ribonucleic Acids in Brain Tumors. Therapeutic Ribonucleic Acids in Brain Tumors
103
124
.
M. L. M. Lamfers & E. A. Chiocca. 2009. Textbook of Stereotactic and Functional Neurosurgery. Textbook of Stereotactic and Functional Neurosurgery
3083
3116
.
Matthew A. Tyler, Adam Quasar Sugihara, Ilya V. Ulasov & Maciej S. Lesniak. 2009. Pharmaceutical Perspectives of Cancer Therapeutics. Pharmaceutical Perspectives of Cancer Therapeutics
475
519
.
Suvobroto Nandi, Ilya V. Ulasov, Matthew A. Tyler, Adam Quasar Sugihara, Luciana Molinero, Yu Han, Zeng B. Zhu & Maciej S. Lesniak. (2008) Low-Dose Radiation Enhances Survivin-Mediated Virotherapy against Malignant Glioma Stem Cells. Cancer Research 68:14, pages 5778-5784.
Crossref
Adam M. Sonabend, Ilya V. Ulasov, Matthew A. Tyler, Angel A. Rivera, James M. Mathis & Maciej S. Lesniak. (2008) Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma. Stem Cells 26:3, pages 831-841.
Crossref